Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
DEPARTMENT OF PEDIATRICS CRISBERT I. CUALTEROS, M.D.
Dengue Fever/Dengue Hemorrhagic Fever <ul><li>4 serotypes (1-4) </li></ul><ul><li>Dengue virus- enveloped RNA arbovirus, F...
 
<ul><li>Dengue Fever: </li></ul><ul><li>Is a benign syndrome caused by several arthropod-borne viruses </li></ul><ul><li>C...
<ul><li>Dengue Hemorrhagic Fever: </li></ul><ul><li>Severe, fatal, febrile disease </li></ul><ul><li>Char: capillary perme...
<ul><li>WHO Criteria for diagnosis of DHF : </li></ul><ul><li>Fever </li></ul><ul><li>Major/minor hemorrhagic manifestatio...
<ul><li>Dengue Shock Syndrome: </li></ul><ul><li>DHF + </li></ul><ul><li>Hypotension </li></ul><ul><li>Narrow pulse pressu...
Pathogenesis of DHF: <ul><li>Increase capillary fragility-  immune- complex rxn similar to anaphylactoid rxn that produce ...
Pathogenesis of DHF: <ul><li>Dec blood coagulation factor(fibrinogen) and Factors II,V,VII,and IX. </li></ul>
Hypothesis that explain why DHF occurs in some individuals: <ul><li>Changes in virulence in some serotypes </li></ul><ul><...
Antibody –dependent enhancement of infection: <ul><li>most popular </li></ul><ul><li>Person who develop antibody from 1 st...
Clinical manifestations: <ul><li>Maculopapular rash (Herman’s rash)- 5 th  to 7 th  day of illness </li></ul><ul><li>Fever...
<ul><li>Anorexia, vomiting with abdominal pain </li></ul><ul><li>Temperature- biphasic </li></ul><ul><li>2 ND  / 3 RD  DAY...
Stages : <ul><li>Febrile Stage  ( 1-4 days ) </li></ul><ul><ul><li>Sudden onset of fever & Headache </li></ul></ul><ul><ul...
<ul><li>Afebrile Stage ( 5- 7 days ) </li></ul><ul><ul><li>Lethargy </li></ul></ul><ul><ul><li>More sever abdominal pain <...
<ul><li>Convalescent Stage  </li></ul><ul><ul><li>Improvement of appetite </li></ul></ul><ul><ul><li>Petechial rash  </li>...
Grading of DHF acc to severity: <ul><li>Grade 1: fever, non-specific symptoms, (+) torniquet test </li></ul><ul><li>Grade ...
Tourniquet test procedure <ul><ul><li>Get blood pressure properly by covering 2/3 of arm with cuff </li></ul></ul><ul><ul>...
Clinical Criteria of DHF: <ul><li>Fever w/ acute onset, high continuous, lasting 2-7 days </li></ul><ul><li>(+) toniquet t...
Laboratory criteria of DHF: <ul><li>Plt 100,000 or less </li></ul><ul><li>Hemoconcentration – hct increased by 20% or more...
<ul><li>Primary infection – no detectable antibody in acute phase serum samples collected on or before day 5 of illness </...
Treatment: <ul><li>DF: </li></ul><ul><ul><li>Supportive </li></ul></ul><ul><ul><li>Bedrest </li></ul></ul><ul><ul><li>Anti...
<ul><li>DHF: </li></ul><ul><ul><li>Immediate evaluation of vital signs and degrees of hemoconcentration, dehydration and e...
<ul><li>Oxygen– cyanotic/labored breathing </li></ul><ul><li>Rapid IV replacement of fluids and electrolytes can sustain p...
Prognosis <ul><li>DF- adversely affected by passively acquired antibody or by prior infection with a closely related virus...
<ul><li>DHF-death has occurred in 40-50% of patients with shock </li></ul><ul><ul><ul><li>Survival is directly related to ...
Criteria for discharge <ul><li>Absence of fever for 46 hours </li></ul><ul><li>Return of appetite </li></ul><ul><li>Visibl...
Prevention <ul><li>Avoiding mosquito bites by use of insecticides, repellants, body covering with clothing, screening of h...
thank you
Upcoming SlideShare
Loading in …5
×

Dengue Fever

23,903 views

Published on

dengue fever in cebu city, philippines

Published in: Health & Medicine

Dengue Fever

  1. 1. DEPARTMENT OF PEDIATRICS CRISBERT I. CUALTEROS, M.D.
  2. 2. Dengue Fever/Dengue Hemorrhagic Fever <ul><li>4 serotypes (1-4) </li></ul><ul><li>Dengue virus- enveloped RNA arbovirus, Family Flaviviridae </li></ul><ul><li>Aedes aegypti – day biting female mosquito </li></ul><ul><li>Incubation period: 4-6 days </li></ul>
  3. 4. <ul><li>Dengue Fever: </li></ul><ul><li>Is a benign syndrome caused by several arthropod-borne viruses </li></ul><ul><li>Char: biphasic fever, myalgia/arthralgia, rash, leukopenia and LAD </li></ul>
  4. 5. <ul><li>Dengue Hemorrhagic Fever: </li></ul><ul><li>Severe, fatal, febrile disease </li></ul><ul><li>Char: capillary permeability, abnormalities of hemostasis, and severe – protein-losing shock syndrome(DSS) </li></ul>
  5. 6. <ul><li>WHO Criteria for diagnosis of DHF : </li></ul><ul><li>Fever </li></ul><ul><li>Major/minor hemorrhagic manifestations </li></ul><ul><li>Thrombocytopenia (<=100,000) </li></ul><ul><li>Objective evidence of capillary permeability( inc HCT =20%, pleural effusion, hypoalbuminemia) </li></ul>
  6. 7. <ul><li>Dengue Shock Syndrome: </li></ul><ul><li>DHF + </li></ul><ul><li>Hypotension </li></ul><ul><li>Narrow pulse pressure (=20 mmHg) </li></ul>
  7. 8. Pathogenesis of DHF: <ul><li>Increase capillary fragility- immune- complex rxn similar to anaphylactoid rxn that produce toxic substances (histamines, serotonin, bradykinins) which damage capillary walls </li></ul><ul><li>Thrombocytopenia -faulty maturation of megakaryocytes – dec production of plt </li></ul><ul><ul><li>Consumption of plt due to generalized intravascular clotting </li></ul></ul>
  8. 9. Pathogenesis of DHF: <ul><li>Dec blood coagulation factor(fibrinogen) and Factors II,V,VII,and IX. </li></ul>
  9. 10. Hypothesis that explain why DHF occurs in some individuals: <ul><li>Changes in virulence in some serotypes </li></ul><ul><li>Virus interaction with environment/ infectious agent </li></ul><ul><li>Differences in genetic susceptibility/ host factors </li></ul><ul><li>Immunologic enhancement of dengue infection by antibody acquired from previous infections with different dengue serotype. </li></ul>
  10. 11. Antibody –dependent enhancement of infection: <ul><li>most popular </li></ul><ul><li>Person who develop antibody from 1 st infection fail to neutralize a 2 nd dengue viral infection and even enhance the entry of virus to monocytes and macrophages – inc viral load and larger # of infected cells </li></ul>
  11. 12. Clinical manifestations: <ul><li>Maculopapular rash (Herman’s rash)- 5 th to 7 th day of illness </li></ul><ul><li>Fever (39-40C), acute in onset </li></ul><ul><li>Headache, periorbital pain, joint pains, and rash </li></ul><ul><li>Patient is flushed and acutely ill </li></ul><ul><li>Conjunctival injection </li></ul>
  12. 13. <ul><li>Anorexia, vomiting with abdominal pain </li></ul><ul><li>Temperature- biphasic </li></ul><ul><li>2 ND / 3 RD DAY – hyperpyrexia persists </li></ul><ul><li>Palms and soles are flushed </li></ul><ul><li>torniquet test often (+) </li></ul><ul><li>Petechiae seen in pressure areas </li></ul><ul><li>5 th – 7 th day – Herman’s Rash w/c last for 2-3 days </li></ul>
  13. 14. Stages : <ul><li>Febrile Stage ( 1-4 days ) </li></ul><ul><ul><li>Sudden onset of fever & Headache </li></ul></ul><ul><ul><li>Flushed skin </li></ul></ul><ul><ul><li>Anorexia, vomiting, abdominal pain </li></ul></ul><ul><ul><li>Hepatomegaly </li></ul></ul><ul><ul><li>Petechial observed in pressure areas ( tourniquet test ) </li></ul></ul>
  14. 15. <ul><li>Afebrile Stage ( 5- 7 days ) </li></ul><ul><ul><li>Lethargy </li></ul></ul><ul><ul><li>More sever abdominal pain </li></ul></ul><ul><ul><li>Restlessness </li></ul></ul><ul><ul><li>Hemorrhagic manifestation ( epistaxis, gum bleeding ) </li></ul></ul>
  15. 16. <ul><li>Convalescent Stage </li></ul><ul><ul><li>Improvement of appetite </li></ul></ul><ul><ul><li>Petechial rash </li></ul></ul><ul><ul><ul><li>Herman’s rash </li></ul></ul></ul><ul><ul><ul><li>Good prognostic sign </li></ul></ul></ul><ul><ul><ul><li>Glove & Stocking’s rash </li></ul></ul></ul><ul><ul><ul><li>Pruritic </li></ul></ul></ul>
  16. 17. Grading of DHF acc to severity: <ul><li>Grade 1: fever, non-specific symptoms, (+) torniquet test </li></ul><ul><li>Grade 2: grade 1 + spontaneous bleeding </li></ul><ul><li>Grade 3: grade 1 &2 + circulatory failure (rapid weak pulses, narrow pulse pressure 20 or less), hypotension, cold clammy skin and restlessness </li></ul><ul><li>Grade 4: profound shock </li></ul>
  17. 18. Tourniquet test procedure <ul><ul><li>Get blood pressure properly by covering 2/3 of arm with cuff </li></ul></ul><ul><ul><li>Get the mean blood pressure : </li></ul></ul><ul><ul><li>Mean blood pressure = systole + diastole / 2 </li></ul></ul><ul><ul><li>Maintain for 5-10 minutes at mean blood pressure </li></ul></ul><ul><ul><li>Check for petechiae using a 1x1 inch opening on a cardboard </li></ul></ul><ul><ul><li>A positive tourniquet test means at least 20 Petechiae per square inch </li></ul></ul>
  18. 19. Clinical Criteria of DHF: <ul><li>Fever w/ acute onset, high continuous, lasting 2-7 days </li></ul><ul><li>(+) toniquet test and any of petechiae, purpura, ecchymosis, gum bleeding and epistaxis </li></ul><ul><li>Hepatomegaly </li></ul><ul><li>shock </li></ul>
  19. 20. Laboratory criteria of DHF: <ul><li>Plt 100,000 or less </li></ul><ul><li>Hemoconcentration – hct increased by 20% or more </li></ul><ul><li>WBC in DHF is variable </li></ul>
  20. 21. <ul><li>Primary infection – no detectable antibody in acute phase serum samples collected on or before day 5 of illness </li></ul><ul><li>Secondary infection – antibody titer is detectable in the early acute phase serum </li></ul>
  21. 22. Treatment: <ul><li>DF: </li></ul><ul><ul><li>Supportive </li></ul></ul><ul><ul><li>Bedrest </li></ul></ul><ul><ul><li>Antipyretics/Analgesics </li></ul></ul><ul><ul><li>Aspirin is contraindicated </li></ul></ul><ul><ul><li>Fluid and electrolyte replacement of deficits by sweating, fasting, thirsting, vomiting and diarrhea. </li></ul></ul>
  22. 23. <ul><li>DHF: </li></ul><ul><ul><li>Immediate evaluation of vital signs and degrees of hemoconcentration, dehydration and electrolyte imbalance. </li></ul></ul><ul><ul><li>Close monitoring is essential for at least 48 hr because shock may occur or recur precipitously early in the disease. </li></ul></ul>
  23. 24. <ul><li>Oxygen– cyanotic/labored breathing </li></ul><ul><li>Rapid IV replacement of fluids and electrolytes can sustain patients until spontaneous recovery occurs. </li></ul><ul><li>Avoid overhydration- contribute to cardiac failure. </li></ul><ul><li>Transfusions of fresh blood or platelets suspended in plasma– control bleeding </li></ul>
  24. 25. Prognosis <ul><li>DF- adversely affected by passively acquired antibody or by prior infection with a closely related virus that predisposes to development of dengue hemorrhagic fever. </li></ul>
  25. 26. <ul><li>DHF-death has occurred in 40-50% of patients with shock </li></ul><ul><ul><ul><li>Survival is directly related to early and intense supportive treatment </li></ul></ul></ul><ul><ul><ul><li>Residual brain damage caused by prolonged shock or by intracranial hemorrhage. </li></ul></ul></ul>
  26. 27. Criteria for discharge <ul><li>Absence of fever for 46 hours </li></ul><ul><li>Return of appetite </li></ul><ul><li>Visible clinical improvement </li></ul><ul><li>Good urine output </li></ul><ul><li>Stable hematocrit </li></ul><ul><li>Recovery from shock </li></ul><ul><li>Platelet count of 150,000 </li></ul>
  27. 28. Prevention <ul><li>Avoiding mosquito bites by use of insecticides, repellants, body covering with clothing, screening of houses </li></ul><ul><li>Elimination of A. aegypti breeding sites </li></ul><ul><li>Insecticides/Larvicide </li></ul><ul><li>Fogging </li></ul><ul><li>Vaccine – Sabin-Schiessinger Vaccine (attenuated dengue virus) </li></ul>
  28. 29. thank you

×